FDA oversight
January 12th, 2009
Here’s pretty damning critique in the NY Times, of FDA oversight of clinical drug trials:
F.D.A. Is Lax on Oversight During Trials, Inquiry Finds.
It just goes to show that no matter what the rules or guidelines say on paper, if they’re not enforced and part of the insitutional culture, they’re not worth the paper they’re printed on!